Neurescue
Pre-clinicalThe First and Only Treatment Approved for Non-Shockable Cardiac ArrestNow CE Marked (NB 2443)
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $24.8M
About
The First and Only Treatment Approved for Non-Shockable Cardiac ArrestNow CE Marked (NB 2443)
Medical DevicesCardiovascular
Funding History
4Total raised:$24.8M
Series A$8MJan 15, 2022
Series A$12MOct 15, 2021
Seed$2MJun 15, 2020
Seed$2.8MMay 15, 2019